Synthesis of a tricyclic tetraazatriacetic ligand for gadolinium(III) as potential contrast agent for MRI

Tetrahedron

Volumn 63, Issue 1, 2007, Pages 204-214

  Dioury, Fabienne ^a   Sambou, Sophie ^a   Guéné, Emmanuelle ^a   Sabatou, Monique ^b   Ferroud, Clotilde ^a   Guy, Alain ^a   Port, Marc ^b  

^a Bioinformatique et Chimie Moléculaire   (France)

^b Laboratoire Guerbet   (France)

Author keywords

Contrast agent for MRI; Gadolinium complex; Macrocyclic polyaza polycarboxylic acid; PCTA12 derivative

Indexed keywords

3,10,13,19 TETRAAZA TRICYCLO[13.3.1.0 4.9 ]NONADECA 1(19),15,17 TRIENE 3,10,13 TRIACETIC ACID; AMINE; CONTRAST MEDIUM; ETHYLENE; GADOLINIUM;

ANALYTIC METHOD; ARTICLE; CHEMICAL ANALYSIS; COMPLEX FORMATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STOICHIOMETRY;

EID: 33751579155     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.10.024     Document Type: Article

References (39)

1. Caravan P., Ellison J.J., McMurry T.J., and Lauffer R.B. Chem. Rev. 99 (1999) 2293-2352
2. Rohrer M., Bauer H., Mintorovitch J., Requardt M., and Weinmann H.-J. Invest. Radiol. 40 (2005) 715-724
3. Jacques V., and Desreux J.F. Top. Curr. Chem. 221 (2002) 123-164
4. Aime S., Fasano M., and Terreno E. Chem. Soc. Rev. 27 (1998) 19-29
5. Jaszberenyi Z., Sour A., Toth E., Benmelouka M., and Merbach A.E. Dalton Trans. (2005) 2713-2719
6. Ranganathan R.S., Raju N., Fan H., Zhang X., Tweedle M.F., Desreux J.F., and Jacques V. Inorg. Chem. 41 (2002) 6856-6866
7. Comblin V., Gilsoul D., Hermann M., Humblet V., Jacques V., Mesbahi M., Sauvage C., and Desreux J.F. Coord. Chem. Rev. 185-186 (1999) 451-470
8. Aime S., Botta M., Crich S.G., Giovenzana G.B., Jommi G., Pagliarin R., and Sisti M. Inorg. Chem. 36 (1997) 2992-3000
9. Aime S., Botta M., Frullano L., Crich S.G., Giovenzana G., Pagliarin R., Palmisano G., Sirtori F.R., and Sisti M. J. Med. Chem. 43 (2000) 4017-4024
10. Aime S., Gianolio E., Corpillo D., Cavallotti C., Palmisano G., Sisti M., Giovenzana G.B., and Pagliarin R. Helv. Chim. Acta 86 (2003) 615-632
11. Dioury F., Sylvestre I., Siaugue J.-M., Wintgens V., Ferroud C., Favre-Réguillon A., Foos J., and Guy A. Eur. J. Org. Chem. (2004) 4424-4436
12. Siaugue J.-M., Segat-Dioury F., Sylvestre I., Favre-Reguillon A., Foos J., Madic C., and Guy A. Tetrahedron 57 (2001) 4713-4718
13. Galaup C., Carrie M.-C., Tisnes P., and Picard C. Eur. J. Org. Chem. (2001) 2165-2175
14. Galaup C., Couchet J.M., Picard C., and Tisnes P. Tetrahedron Lett. 42 (2001) 6275-6278
15. Kan T., and Fukuyama T. Chem. Commun. (2004) 353-359
16. Sodergren M.J., Alonso D.A., Bedekar A.V., and Andersson P.G. Tetrahedron Lett. 38 (1997) 6897-6900
17. Müller P., Baud C., Jacquier Y., Moran M., and Naegeli I. J. Phys. Org. Chem. 9 (1996) 341-347
18. Bridger, G.; Skerlj, R.; Kaller, A.; Harwig, C.; Bogucki, D.; Wilson, T. R.; Crawford, J.; McEachern, E. J.; Atsma, B.; Nan, S.; Zhou, Y.; Schols, D. PCT Int. Appl., WO0056729, 2000.
19. Dioury F., Guené E., Di Scala-Roulleau A., Ferroud C., Guy A., and Port M. Tetrahedron Lett. 46 (2005) 611-613
20. Kirsanov A.V., and Kirsanova N.A. J. Gen. Chem. USSR 32 (1962) 887-892
21. Hidai Y., Kan T., and Fukuyama T. Tetrahedron Lett. 40 (1999) 4711-4714
22. Wilson M.E., and Nowick J.S. Tetrahedron Lett. 39 (1998) 6613-6616
23. Aicher, T. D.; Chen, Z.; Chen, Y.; Faul, M. M.; Krushinski, J. H., Jr.; Le Huerou, Y.; Pineiro-Nunez, M. M.; Rocco, V. P.; Ruley, K. M.; Schaus, J. M.; Thompson, D. C.; Tupper, D. E. PCT Int. Appl., WO03082877, 2003.
24. Johnson, F.; Gupta, R. C. PCT Int. Appl., WO9852552, 1998.
25. Tsangaris J.M., and Baxevanidis G.T. Hem. Hron., Nei Seira 1 (1972) 247-254
26. 2), 170.7 (CO) ppm.
27. 2+ (5%).
28. Fukuyama T., Jow C.-K., and Cheung M. Tetrahedron Lett. 36 (1995) 6373-6374
29. +.
30. 13C NMR spectra of the expected product 18 obtained later from Route B proved to be identical to these ones. Moreover, the m/z 489 signal corresponding to the di-N-alkylated product was also present, but in lesser abundance (<5%), in the low-resolution mass spectrum of product 18 obtained from Route B. These results led us to conclude that, at least, a part of the m/z 489 signal may result from a fragmentation process during the mass spectrometric analysis. In this case, a prolonged reaction with other portions of alkylating agent and base would probably have led to the tri-N-alkylated product 18 exclusively.
31. By using a 2-fold excess of alkylating agent, the reaction was rendered regioselective as the mono-N-alkylated product 21 was isolated in 88% yield.
32. Rew Y., and Goodman M. J. Org. Chem. 67 (2002) 8820-8826
33. Nihei K.-I., Kato M.J., Yamane T., Palma M.S., and Konno K. Synlett (2001) 1167-1169
34. + (97%).
35. Nachman, I.; Port, M.; Raynal, I.; Rousseaux, O. PCT Int. Appl., WO03074523, 2003.
36. Hovland R., Glogard C., Aasen A.J., and Klaveness J. Org. Biomol. Chem. 1 (2003) 644-647
37. Port M., Raynal I., Vander Elst L., Muller R.M., Dioury F., Ferroud C., and Guy A. Contrast Med. Mol. Imag. 1 (2006) 121-127
38. Müller P., Baud C., and Jacquier Y. Tetrahedron 52 (1996) 1543-1548
39. Kumar K., Chang C.A., and Tweedle M.F. Inorg. Chem. 32 (1993) 587-593